Our Team

Francesca Fox

  • With over a decade of experience in VWC technology and as a previous co-founder of four companies, Francesca Fox brings a wealth of knowledge to NEWAVX. Since the company's inception in 2021, she has successfully led NEWAVX to profitability right from the start, achieving an impressive 60% increase in turnover year on year. Her deep expertise in the development and commercialisation of VWC therapy products equips her with a profound understanding of technology, market dynamics, and customer needs—key elements that form the strong foundation of our success.


    Francesca believes that the most valuable asset we have is our team, which is essential for driving great innovation. She prioritises a balanced approach that empowers individuals, encourages creativity, and fosters growth through calculated risk-taking. Her personal journey with dyslexia has profoundly shaped her leadership style; by recognising her limitations and leveraging the unique strengths of her team, she creates an inclusive environment where everyone can contribute to collective success.


    In 2021, Francesca was recognised as a "30 Under 30" One to Watch, highlighting her potential and impact in her field. As noted by an Innovate UK assessor, “Francesca displays a remarkable ability to transform challenges into innovative opportunities. Her unique perspective and inclusive leadership empower her team to leverage their diverse strengths, driving collaboration and growth in the face of adversity.”


    As co-leader of the Continuing Professional Development (CPD) program, Francesca has established a benchmark for excellence in veterinary care market penetration. Under her guidance, the program has earned accolades from veterinarians and insurance companies alike, showcasing her ability to build vital relationships. Her partnerships with leading insurance providers, including NFU Mutual and Beazley Insurance, are crucial for NEWAVX's future growth and strategy, as collaborating with insurance companies remains a cornerstone of our approach.


    Francesca has spearheaded team efforts that have contributed over $28 million to VWC's revenue growth, driven by a relentless commitment to exceptional customer service and product support. Her leadership style cultivates a culture of innovation and collaboration, empowering her team to push the boundaries of what is possible in the healthcare sector.


    Passionate about advancing healthcare solutions, Francesca’s vision and dedication pave the way for NEWAVX's mission to enhance the lives of patients while setting new standards of excellence in the industry.

CEO & Co-Founder, NEWAVX

Dominic Fox

  • With over 15 years of experience in professional sports, Dominic Fox brings a wealth of knowledge and insight to NEWAVX. As a co-founder, he leverages his extensive background to understand the unique needs of elite athletes, physiotherapists, and the intricacies of injury recovery. Dominic’s unwavering resilience and commitment to excellence are at the core of his leadership philosophy. He believes that effective leadership requires a harmonious blend of bold innovation and precise execution, driving the team towards success. His personal experience living with ADHD fuels his creative approach to problem-solving, allowing him to foster an inclusive culture where every team member feels empowered and inspired to contribute.


    Dominic has been instrumental in the successful launch of VWC therapy products in five major countries, showcasing an exceptional ability to navigate international markets and forge strong partnerships. A highlight of this expansion is the launch in the UAE, where he played a key role in securing a strategic deal worth £350,000 for zero outlay to the company for a world-ranking sporting event.


    Under Dominic's leadership, NEWAVX secured a prestigious £150,000 grant from Innovate UK for a collaborative project with the University of Birmingham, guided by Professor Leigh Breen. This achievement underscores his commitment to fostering innovation and advancing healthcare solutions through impactful partnerships.


    Passionate about Environmental, Social, and Governance (ESG) values, Dominic is dedicated to ensuring that NEWAVX's mission reflects a commitment to positive impact and sustainable practices. His vision and drive support our goal of transforming healthcare and enhancing the lives of patients everywhere.

CMO & Co-Founder, NEWAVX

Dr. Rebecca Marchmont

Chief Clinical Advisor & Lead Safeguarding GP, NEWAVX

  • We are proud to introduce Dr. Rebecca Marchmont, our Chief Clinical Advisor and Lead Safeguarding GP with over a decade of experience in general practice. Specialising in geriatric care, Dr. Marchmont is dedicated to enhancing the health and well-being of older adults through innovative approaches and compassionate care, making her an invaluable asset to our team and the wider community.


    As the Head of Dementia United within the Greater Manchester Integrated Care Partnership, Dr. Marchmont promotes integrated care across the region while spearheading national initiatives that address unmet health needs. She oversees wellness solutions at our clinics, ensuring high-quality, ethical care, and provides clinical support to clinic directors, fostering a culture of collaboration and continuous improvement.


    Dr. Marchmont’s expertise in geriatric care and dementia greatly influences our preventive strategies and the development of non-pharmaceutical pain management options. Her commitment to reducing opioid reliance aligns with our mission to revolutionise healthcare through technology and personalised solutions, empowering healthcare professionals to adopt a more patient-centred approach.


    With a strong focus on patient advocacy, Dr. Marchmont is dedicated to empowering patients and enhancing connections between them and their healthcare providers. Her leadership, innovative mindset, and commitment to education in geriatric care further strengthen our vision of improving patient outcomes and the future of healthcare.

Prof. Leigh Breen

Leading Research in Muscle Physiology, University of Birmingham

  • We are thrilled to collaborate with Professor Leigh Breen, a distinguished expert in skeletal muscle physiology at the University of Birmingham. As the Director of the Metabolic and Molecular Physiology Group and the inaugural Chair of the Centre for Movement and Wellbeing, Professor Breen leads pioneering research that explores the impact of exercise and nutrition on muscle health across all ages. His work, which has received significant funding from Innovate UK and organisations like UKRI, focuses on addressing health inequalities through initiatives such as the UKRI-funded ‘ATTAIN’ Network. 

Dr. Jonathan Quinlan

Dr. Alex Waddell

University of Birmingham 

University of Birmingham:
A Leader in Research Excellence

The University of Birmingham is consistently ranked 6th in the UK and is renowned for its commitment to research excellence and innovative teaching. As a proud member of the Russell Group, the University plays a pivotal role in shaping higher education while addressing pressing global challenges. Our interdisciplinary approach fosters collaboration across diverse fields of study, driving groundbreaking research that impacts society significantly.

Left to right  — Prof Leigh Breen, Dr Jonathan Quinlan, Francesca Fox, Dominic Fox & Dr Alex Wadley

School of Sport, Exercise and Rehabilitation Sciences

At the forefront of this innovative research is the School of Sport, Exercise and Rehabilitation Sciences, celebrated as a hub for cutting-edge studies that advance human health and performance. Under the leadership of notable experts, including Professor Leigh Breen, the School investigates the intricate relationships between exercise, nutrition, and physical well-being.

Together, we are dedicated to promoting health equity and enhancing outcomes for individuals across diverse populations. By leveraging the University of Birmingham’s robust research environment and extensive partnerships with healthcare organisations and industry leaders, we are well-positioned to drive transformative initiatives aimed at improving the quality of life for communities both locally and globally.

For more detailed information on our research and its implications, please visit our project page: Understanding the Musculoskeletal and Physiological Effects of VO.
Together, we are dedicated to advancing the understanding of health and well-being, fostering innovations that will drive meaningful change both locally and globally.